author-photo

Oleh Zagrijtschuk

15

Papers

143

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

The Design of a Phase 2 Study to Evaluate the Safety and Efficacy of Ropeginterferon Alfa-2b (P1101) in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea (HU)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration.

2021 Clinical Drug Investigation
Show All
- Source
- Cite
- Save
Citations (1)
Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Hematopoietic expression of a chimeric murine-human CALR oncoprotein allows the assessment of anti-CALR antibody immunotherapies in vivo.

2021 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Innovation in the pharmaceutical industry in EU and USA: sources of new medicines over the period of 1996-2016

2021
- Oleh Zagrijtschuk
Show All
- Source
- Cite
- Save
Citations (0)
The Rationale, Design, and Baseline Characteristics of a Phase 2 Study to Evaluate the Safety and Efficacy of Ropeginterferon Alfa-2b (P1101) in Japanese Patients with Polycythemia Vera for Whom the Current Standard of Care Is Difficult to Apply

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor.

2020 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Proposal of an endpoint for a phase III clinical study of essential thrombocythemia: Balancing between short term effects and long term benefits.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Clinical Benefit of Ropeginterferon Alfa 2b (P1101) in Patients with Myelofibrosis

2018 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg‐proline‐interferon alpha‐2b

2015 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (35)